secwatch.observer — SEC 8-K summary
======================================

Issuer:     MADRIGAL PHARMACEUTICALS, INC. (MDGL)
CIK:        0001157601
Form:       8-K
Filed at:   2023-06-20T23:59:59+00:00
Accession:  0001193125-23-169190
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Madrigal appoints Julian Baker as Chairman, adds two Baker Bros. affiliates to board
--------------------------------------------------------------------------------

- Keith Gollust and David Milligan resigned as Class III directors effective June 15, 2023; no disagreement cited.
- Julian Baker appointed independent Chairman; Raymond Cheong also appointed as Class III director.
- Both new directors are affiliated with Baker Bros. Advisors LP, a significant shareholder.
- Baker Bros. waived director nomination rights under Securities Purchase Agreement while Baker or Cheong serve.
- CEO Paul Friedman remains; Chairman and CEO roles separated.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1157601/000119312523169190/0001193125-23-169190-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1157601/000119312523169190/d480541d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-169190

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer